|
|
|
|
Vol. 62, Issue 1, 75-80, July 2002
Departments of Neurosurgery (Y.K., N.H.) and Pharmacology (Y.K., Y.O., S.M., T.M.), Kyoto University Faculty of Medicine, Kyoto, Japan
| |
Abstract |
|---|
|
|
|---|
We demonstrated recently that in Chinese hamster ovary cells stably
expressing human recombinant endothelinA receptors
(CHO-ETAR), endothelin-1 (ET-1) activates two types of
Ca2+-permeable nonselective cation channels (designated
NSCC-1 and NSCC-2) and a store-operated Ca2+ channel
(SOCC), which can be distinguished by Ca2+ channel blockers
such as
1-{
-[3-(4-methoxyphenyl)propoxy]-4-methoxyphenylethyl}-1H-imidazole hydrochloride (SK&F 96365) and
(R,S)-(3,4-dihydro-6,7-dimethoxy-isochinolin-1-yl)-2-phenyl-N,N-di[2-(2,3,4-trimethoxyphenyl)ethyl]acetamid mesylate (LOE 908). We also reported that CHO-ETAR couples
with G12 in addition to Gq and Gs.
The purpose of the present study was to identify the G proteins
involved in the activation of these Ca2+ channels by ET-1,
using mutated ETARs with coupling to either Gq
or Gs/G12 (designated ETAR
385
and SerETAR, respectively) and a dominant-negative mutant
of G12 (G12G228A). ETAR
385 is
truncated immediately downstream of Cys385 in the C
terminus as palmitoylation sites, whereas SerETAR is unpalmitoylated because of substitution of all the cysteine residues to
serine (Cys383Cys385-388
Ser383Ser385-388). In
CHO-ETAR
385, stimulation with ET-1 activated only SOCC. In CHO-SerETAR or CHO-ETAR pretreated with
U73122, an inhibitor of phospholipase C (PLC), ET-1 activated only
NSCC-1. Dibutyryl cAMP alone did not activate any Ca2+
channels in the resting and ET-1-stimulated CHO-SerETAR.
Microinjection of G12G228A abolished the activation of
NSCC-1 and NSCC-2 in CHO-ETAR and that of NSCC-1 in
CHO-SerETAR. These results indicate that ETAR
activates three types of Ca2+ channels via different G
protein-related pathways. NSCC-1 is activated via a
G12-dependent pathway, NSCC-2 via Gq/PLC- and G12-dependent pathways, and SOCC via a
Gq/PLC-dependent pathway.
| |
Introduction |
|---|
|
|
|---|
Endothelin-1
(ET-1), a 21-amino acid peptide, is one of the most potent endogenous
vasoconstricting agents (Yanagisawa et al., 1988
). Subsequent studies
have described its multiple and wide-ranging biological activities,
including modulation of neurotransmission (Koseki et al., 1989
) and
stimulation of cell proliferation (Komuro et al., 1988
; Shichiri et
al., 1991
). Recent reports have demonstrated that extracellular
Ca2+ influx through voltage-independent
Ca2+ channels (VICCs) plays a critical role for
ET-1-induced contraction of rat aorta (Zhang et al., 1999
) and
ET-1-induced proliferation of vascular smooth muscle cells (VSMCs)
(Kawanabe et al., 2002a
). Thus, it is important to elucidate activation
mechanisms of VICCs by ET-1. Biological actions of ET-1 are mediated by
two distinct receptor subtypes: endothelinA and
endothelinB receptors
(ETARs and ETBRs,
respectively), which belong to a family of G protein-coupled receptors
(Arai et al., 1990
; Sakurai et al., 1990
). Therefore, in the present
study, we focused on investigating which G protein subtypes were
involved in the activation of each Ca2+ channel
by ET-1.
Transfection and functional expression of wild-type or mutant
ETAR cDNAs into the same cell type provides a
model system for study of the precise characteristics of signal
transduction by a single receptor subtype. We used Chinese hamster
ovary (CHO) cells stably expressing wild-type or mutant
ETARs in this study. We have recently shown that
a sustained increase in intracellular free Ca2+
concentration ([Ca2+]i)
caused by ET-1 results from Ca2+ entry through
three types of VICCs into CHO cells stably expressing wild-type
ETAR (CHO-ETAR): two types
of Ca2+-permeable nonselective cation channels
(designated NSCC-1 and NSCC-2) and a store-operated
Ca2+ channel (SOCC) (Kawanabe et al., 2001
). In
particular, these channels can be distinguished using
Ca2+ channel blockers such as SK&F 96365 and LOE
908. Thus, NSCC-1 is sensitive to LOE 908 and resistant to SK&F 96365, NSCC-2 is sensitive to both LOE 908 and SK&F 96365, and the SOCC is
resistant to LOE 908 and sensitive to SK&F 96365 (Kawanabe et al.,
2001
). The VICCs activated by ET-1 in CHO-ETAR
are pharmacologically identical to those in VSMCs (Kawanabe et al.,
2002a
). Therefore, CHO-ETAR may be a good model
for studying the mechanism of activation of VICCs.
ETARs are functionally coupled with
Gq and Gs in CHO cells
(Aramori and Nakanishi, 1992
). Activation of Gq
and Gs causes stimulation of phospholipase C
(PLC) and adenylyl cyclase, respectively (Aramori and Nakanishi, 1992
).
In addition, ETARs also couple with
G12 via its C terminus to induce actin stress
fiber formation in CHO cells (Kawanabe et al., 2002b
). In the present
study, we used a dominant-negative mutant of G12
and two types of mutated ETARs designated
ETAR
385 and SerETAR to
clarify the involvement of Gq,
Gs, and G12 for
Ca2+ channel activation by ET-1.
ETAR
385 lacks a C terminus downstream of
Cys385 and couples only with
Gq in CHO cells (Kawanabe et al., 2002b
). SerETAR is unpalmitoylated because of
substitution of all the cysteine residues to serine
(Cys383Cys385-388
Ser383Ser385-388)
and couples with Gs and G12
in CHO cells (Kawanabe et al., 2002b
).
| |
Experimental Procedures |
|---|
|
|
|---|
Cell Culture.
We used CHO-ETAR,
CHO-ETAR
385, and
CHO-SerETAR, which were constructed as described
previously (Kawanabe et al., 2002b
). The
Kd (picomolar) and
Bmax (picomoles per milligram of
protein) values for CHO-ETAR,
CHO-ETAR
385, and
CHO-SerETAR were 52.8 ± 2.4 and 1.08 ± 0.16, 49.5 ± 4.3 and 1.12 ± 0.08, and 70.2 ± 4.4 and 1.04 ± 0.14, respectively. CHO cells were maintained in
Ham's F12 medium supplemented with 10% fetal calf serum under a
humidified 5% CO2/95% air atmosphere.
Measurement of Intracellular Free Ca2+
Concentration.
[Ca2+]i
was measured using the fluorescent probe fluo-3. The measurement of
fluorescence by a CAF 110 spectrophotometer (Jasco, Tokyo, Japan) was
performed as described previously (Kawanabe et al., 2001
).
Fmin) / (Fmax
F), where
F was the experimental value of fluorescence and
Kd was defined as 0.4 µM (Minta et
al., 1989Microinjection.
For microinjection, cells were seeded onto
glass coverslips coated with fibronectin (Iwaki Glass, Chiba, Japan),
which were marked with a cross to facilitate the localization of
injected cells, and were incubated overnight in Ham's F12 medium
containing 1% fetal calf serum. Microinjection of
G12G228A, constructed as described previously
(Kawanabe et al., 2002b
), was performed using a Zeiss microinjection
system (Carl Zeiss). Plasmid (100 ng/µl) was used for microinjection
into the cell nuclei.
Materials. Boehringer Ingelheim GmbH (Ingelheim, Germany) kindly provided LOE 908. Other chemicals were obtained commercially from the following sources: ET-1 from Peptide Institute (Osaka, Japan); SK&F 96365 from Biomol Research Laboratories (Plymouth Meeting, PA); fluo-3/AM from Dojin Laboratories (Kumamoto, Japan); and U73122 from Funakoshi (Tokyo, Japan).
Statistical Analysis. All results were expressed as mean ± S.E.M.
| |
Results |
|---|
|
|
|---|
Basic Properties of the ET-1-Induced Increase in
[Ca2+]i in CHO-ETAR,
CHO-ETAR
385, and CHO-SerETAR.
ET-1
induced a biphasic increase in
[Ca2+]i in
CHO-ETAR, consisting of an initial transient
phase and a subsequent sustained phase (Fig.
1A). Both the transient and sustained
increase in [Ca2+]i were
dependent on the concentrations of ET-1 with EC50
values of approximately 1 nM, and they reached the maximal value at
concentrations
10 nM (Fig. 1, D and E).
|
385, which is coupled with
Gq alone, ET-1 also induced a biphasic increase
in [Ca2+]i (Fig. 1B).
ET-1 caused a transient peak and subsequent sustained increase in
[Ca2+]i (Fig.
2B). The magnitude of the transient
increase in [Ca2+]i in
CHO-ETAR
385 was essentially similar to that in
CHO-ETAR (Fig. 1D). On the other hand, the
magnitude of the sustained increase in
[Ca2+]i in
CHO-ETAR
385 was lower than that in
CHO-ETAR (Fig. 1E). Moreover, an ET-1
concentration
10 nM induced a sustained increase in
[Ca2+]i in
CHO-ETAR
385, whereas ET-1 induced an increase
at only 0.1 nM in CHO-ETAR (Fig. 1E).
|
385. That is, ET-1 failed to induce an
initial transient increase in
[Ca2+]i, and it induced
only a sustained increase in
[Ca2+]i (Fig. 1C). The
magnitude of the sustained increase in
[Ca2+]i in
CHO-SerETAR was lower than that in
CHO-ETAR (Fig. 1E).
Pharmacological Identification of Ca2+ Channels
Activated by ET-1 in CHO-ETAR, CHO-ETAR
385,
and CHO-SerETAR.
As described previously (Kawanabe et
al., 2001
), in CHO-ETAR, the ET-1-induced
sustained increase in
[Ca2+]i was partially
suppressed by the maximally effective concentration (10 µM) of either
SK&F 96365 or LOE 908, and it was abolished by combined treatment with
both blockers (Fig. 2, A and D). In CHO-ETAR
385, the ET-1-induced sustained
increase in [Ca2+]i was
completely inhibited by 10 µM SK&F 96365, whereas LOE 908 at
concentrations up to 10 µM had no effects (Fig. 2, B and E). In
CHO-SerETAR, the ET-1-induced sustained increase
in [Ca2+]i was completely
inhibited by 10 µM LOE 908, whereas SK&F 96365 at concentrations up
to 10 µM had no effects (Fig. 2, C and F).
Effects of Inhibition of PLC on the Species of
ET-1-Activated Ca2+ Channels in CHO-ETAR.
In CHO-SerETAR, coupling between the receptor and
Gq is missing, and hence, PLC as an effector of
Gq cannot be activated upon stimulation of the
receptor. To mimic the stimulation in CHO-SerETAR and confirm that PLC actually acts as an effector for activation of
Ca2+ channels, we used U73122, a PLC blocker.
Previous reports demonstrated that 5 to 10 µM U73122 inhibits PLC
activation completely (Okamoto et al., 1995
; Kanki et al., 2001
). ET-1
stimulated [3H]inositol phosphates (IPs)
formation in CHO-ETAR (Kawanabe et al., 2001
). On
the other hand, ET-1 failed to induce [3H]IPs
formation in CHO-ETAR treated with 5 µM U73122
(data not shown). ET-1 at 10 nM induced only the sustained increase in
[Ca2+]i in
CHO-ETAR treated with 5 µM U73122 (Fig.
3, A and B). The magnitude of the
sustained increase in
[Ca2+]i was approximately
20% of that in the absence of U73122. This sustained increase in
[Ca2+]i was completely
inhibited by 10 µM LOE 908, whereas SK&F 96365 at concentrations up
to 10 µM had no effects (Fig. 3, A and B).
|
Effects of Dibutyryl cAMP on the Resting
[Ca2+]i and the ET-1-Induced Increase in
[Ca2+]i in CHO-SerETAR.
Because CHO-SerETAR is coupled with
Gs and G12 (Kawanabe et
al., 2002b
), it is unknown which of the G proteins is involved in the
activation of Ca2+ channels. To clarify whether
Gs was involved in Ca2+
channel activation, we examined the effects of dibutyryl cAMP on the
resting [Ca2+]i and the
ET-1-induced increase in
[Ca2+]i. A previous
report demonstrated that 1 mM dibutyryl cAMP activates protein kinase A
in CHO cells (Lee and Fraser, 1993
). Dibutyryl cAMP at 1 mM failed to
evoke an increase in
[Ca2+]i in
CHO-SerETAR (Fig. 3C). Moreover, the
ET-1-induced sustained increase in
[Ca2+]i was not affected
by 1 mM dibutyryl cAMP in CHO-SerETAR (Fig. 3D).
Dibutyryl cAMP also failed to affect the resting
[Ca2+]i and the
ET-1-induced increase in
[Ca2+]i in
CHO-ETAR (data not shown).
Effects of G12 on the ET-1-Induced Sustained Increase in [Ca2+]i in CHO-ETAR or CHO-SerETAR. To confirm that G12 is involved in the activation of Ca2+ channels, we investigated the effects of G12G228A on the ET-1-induced increase in [Ca2+]i in CHO-ETAR and CHO- SerETAR. In this experiment, G12G228A was microinjected into CHO-ETAR and CHO-SerETAR, and the ET-1-induced increase in [Ca2+]i in these cells was analyzed using microfluorimetry.
In CHO-ETAR microinjected with G12G228A, ET-1 evoked transient and subsequently sustained increase in [Ca2+]i. The magnitude of the sustained increase in [Ca2+]i was approximately 40% of that in CHO-ETAR microinjected with an expression vector alone (data not shown). The sustained increase in [Ca2+]i was inhibited by 10 µM SK&F 96365, whereas it remained unaffected by 10 µM LOE 908 (Fig. 4A). ET-1 failed to induce a sustained increase in [Ca2+]i in CHO-SerETAR microinjected with G12G228A (Fig. 4B).
|
| |
Discussion |
|---|
|
|
|---|
As reported previously (Kawanabe et al., 2001
), the ET-1-induced
sustained increase in
[Ca2+]i in
CHO-ETAR results from extracellular
Ca2+ influx through three types of VICCs: NSCC-1,
NSCC-2, and SOCC. Pharmacological identification of these
Ca2+ channels and calculation for contribution of
Ca2+ influx through each channel are explained
schematically in Fig. 5. We have
pharmacologically defined these channels in CHO cells expressing human
recombinant ETAR and VSMCs expressing endogenous ETAR and have found that the same
Ca2+ channels are activated in these cells
(Kawanabe et al., 2001
, 2002a
).
|
In CHO-ETAR
385, the only
Ca2+ channels activated by ET-1 are SOCCs,
judging from the sensitivity of the ET-1-induced sustained increase in
[Ca2+]i to SK&F 96365 and
LOE 908 (Fig. 2, B and E). Because CHO-ETAR
385 is coupled with Gq but not with
Gs or G12 (Kawanabe et al.,
2002b
), this result indicates that Gq is required
(sufficient) for activation of SOCC. Furthermore, activation of SOCC in
CHO-ETAR is lost after treatment with U73122
(Fig. 3, A and B), indicating that PLC acts as an effector downstream
of Gq. These results, taken together, show that
SOCC is activated via a Gq/PLC-dependent pathway.
Conversely, the results obtained from
CHO-ETAR
385 suggest that the activation of
NSCC-1 and NSCC-2 requires G proteins other than
Gq. Because CHO-ETAR is
coupled with Gs and G12 in
addition to Gq (Aramori and Nakanishi, 1992
;
Kawanabe et al., 2002b
), activation of NSCC-1 and NSCC-2 might be
mediated by either Gs or
G12. To address this point, we used
CHO-SerETAR, which couples with
Gs and G12 but not with
Gq (Kawanabe et al., 2002b
). In
CHO-SerETAR, ET-1 activated NSCC-1 but not
NSCC-2, because of the pharmacology of the sustained increase in
[Ca2+]i (sensitive to LOE
908 and resistant to SK&F 96365) (Fig. 3, C and D). These results
indicate that either Gs or
G12 is required for activation of NSCC-1, whereas
either Gs, G12, or both are not sufficient for activation of NSCC-2. Regarding a mechanism for
activation of NSCC-1, dibutyryl cAMP alone was without effect in the
resting [Ca2+]i and the
ET-1-induced sustained increase in
[Ca2+]i in
CHO-SerETAR (Fig. 3), excluding the possibility
that activation of NSCC-1 is mediated by cAMP, a product of
Gs/adenylate cyclase-dependent pathway. Moreover,
disruption of signaling through endogenous G12 by
its dominant-negative mutant (G12G228A) abrogated
activation of NSCC-1 in CHO-SerETAR as well as
CHO-ETAR (Fig. 4), indicating that activation of
NSCC-1 is mediated by G12. Taken together, these
results strongly demonstrate that NSCC-1 is activated via a
G12-dependent pathway.
As for a mechanism for activation of NSCC-2, the channel was not
activated in CHO-ETAR pretreated with U73122 or
in CHO-ETAR microinjected with
G12G228A (Figs. 3 and 4). These results indicate that both a Gq/PLC-dependent pathway and a
G12-dependent pathway are required for activation
of NSCC-2. In accordance with this conclusion, NSCC-2 was not activated
after the stimulation of ETAR lacking coupling
with either Gq or G12,
i.e., SerETAR and ETAR
385.
Signaling mechanisms downstream of G proteins are presently unknown. In
the case of Gq, it is very likely that PLC is
activated downstream of Gq, considering that
CHO-ETAR treated with U73122 (an inhibitor of
PLC) mimicked CHO-SerETAR (which lost the ability to couple with Gq) in terms of temporal pattern
and magnitude of the ET-1-induced changes in
[Ca2+]i and species of
activated channels. Stimulation of PLC leads to increased formation of
inositol-1,4,5-trisphosphate and diacylglycerol (DAG).
Inositol-1,4,5-trisphosphate acts on its receptor on sarcoplasmic reticulum as an intracellular Ca2+ store to
release Ca2+ and subsequently deplete the store
(Berridge, 1993
). Thus, the store depletion could be a trigger for
activation of the Ca2+ channels on the plasma
membrane called capacitative Ca2+ channel
(Thasreup et al., 1990
). In fact, SOCC is activated in CHO-ETAR and VSMCs, after depletion of the
Ca2+ store by treatment with thapsigargin (an
inhibitor of Ca2+-pump ATPase on the membrane of
sarcoplasmic reticulum) (Kawanabe et al., 2001
, 2002a
). The
concentrations of ET-1 that failed to induce a transient increase in
[Ca2+]i and IP
accumulation did not induce SOCC activation (Kawanabe et al., 2001
).
Judging from these data, we concluded that the transient increase in
[Ca2+]i (depletion of
Ca2+ from intracellular
Ca2+ store) essentially follows the
characteristics of SOCC. On the other hand, another second messenger,
DAG, can directly activate Ca2+ channels such as
transient receptor potential (Hofmann et al., 1999
). Thus, DAG might be
an effector downstream of Gq. In the case of
G12, several kinds of proteins are reported to be
its effectors (Seasholtz et al., 1999
). We have recently shown that stimulation of CHO-ETAR with ET-1 induces actin
stress fiber formation through G12, and that
downstream of G12, a small GTP-binding protein Rho and
-associated coiled-coil-forming protein kinase is activated (Kawanabe et al., 2002b
). Thus Rho/Rho-associated coiled-coil-forming protein kinase might be a signal downstream of
G12. Additional study is needed to identify the
effectors downstream of Gq and G12 for activation of NSCC-1, NSCC-2, and SOCC.
In summary, stimulation of ETAR with ET-1 activates NSCC-1, NSCC-2, and SOCC in CHO-ETAR. NSCC-1 is activated via a G12-dependent pathway, NSCC-2 is activated via Gq- and G12-dependent pathways, and SOCC is activated via a Gq-dependent pathway.
| |
Acknowledgments |
|---|
We thank Boehringer Ingelheim K.G. for the kind donation of LOE 908.
| |
Footnotes |
|---|
Received December 13, 2001; Accepted March 28, 2002
This work was supported by a Grant-in-Aid from the Ministry of Education, Science, Sports and Culture of Japan, by Special Coordination Funds for Science and Technology from the Science and Technology Agency, by a research grant for cardiovascular disease (11C-1) from the Ministry of Health and Welfare, and by a grant from the Smoking Research Foundation, Japan.
Address correspondence to: Yoshifumi Kawanabe, M.D., Ph.D., Membrane Biology Program, Brigham and Women's Hospital, Harvard Institute of Medicine, Room 520, 77 Avenue Louis Pasteur, Boston, MA 02115. E-mail: ykawanabe{at}rics.bwh.harvard.edu
| |
Abbreviations |
|---|
ET-1, endothelin-1;
VICC, voltage-independent Ca2+ channel;
VSMC, vascular smooth
muscle cell;
ETAR, endothelinA receptor;
ETBR, endothelinB receptor;
CHO, Chinese
hamster ovary;
NSCC, nonselective cation channel;
SOCC, store-operated
Ca2+ channel;
PLC, phospholipase C;
SK&F 96365, 1-{
-[3-(4-methoxyphenyl)propoxy]-4-methoxyphenylethyl}-1H-imidazole
hydrochloride;
LOE 908, (R,S)-(3,4-dihydro-6,7-dimethoxy-isochinolin-1-yl)-2-phenyl-N,N-di[2-(2,3,4-trimethoxyphenyl)ethyl]acetamid
mesylate;
AM, acetoxymethyl ester;
U73122, 1-(6-{[17
-3-methoxyoestra-1,3,5(10)-trien-17-yl]amino}hexyl)-1H-pyrrole-2,5-dione;
IP, inositol phosphate;
DAG, diacylglyceride;
G12G228A, dominant-negative mutant of G12;
CHO-SerETAR, Chinese hamster ovary cells that express an unpalmitoylated
(Cys383Cys385-388
Ser383Ser385-388)
human endothelinA receptor;
CHO-ETAR
385, Chinese hamster ovary cells that express human endothelinA
receptor truncated at the carboxyl-terminal downstream of Cys385;
CHO-ETAR, Chinese hamster ovary cells stably expressing
human endothelinA receptor.
| |
References |
|---|
|
|
|---|
2-adrenergic receptors.
J Biol Chem
268:
7949-4957This article has been cited by other articles:
![]() |
Y. Kawanabe, N. Hashimoto, and T. Masaki Characterization of G proteins involved in activation of nonselective cation channels and arachidonic acid release by norepinephrine/{alpha}1A-adrenergic receptors Am J Physiol Cell Physiol, March 1, 2004; 286(3): C596 - C600. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kawanabe, K. Nozaki, N. Hashimoto, and T. Masaki Characterization of Ca2+ Channels and G Proteins Involved in Arachidonic Acid Release by Endothelin-1/EndothelinA Receptor Mol. Pharmacol., September 1, 2003; 64(3): 689 - 695. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kawanabe, N. Hashimoto, and T. Masaki Effects of Phosphoinositide 3-Kinase on the Endothelin-1-Induced Activation of Voltage-Independent Ca2+ Channels and Mitogenesis in Chinese Hamster Ovary Cells Stably Expressing EndothelinA Receptor Mol. Pharmacol., September 1, 2002; 62(3): 756 - 761. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||